Tuning spacer length improves the functionality of the nanobody-based VEGFR2 CAR T cell
Abstract Background The chimeric antigen receptor-expressing T (CAR-T) cells for cancer immunotherapy have obtained considerable clinical importance. CAR T cells need an optimized intracellular signaling domain to get appropriately activated and also for the proper antigen recognition, the length an...
Main Authors: | Fatemeh Hajari Taheri, Mahmoud Hassani, Zahra Sharifzadeh, Mahdi Behdani, Shahryar Abdoli, Mahtab Sayadi, Kowsar Bagherzadeh, Arash Arashkia, Mohsen Abolhassani |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-01-01
|
Series: | BMC Biotechnology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12896-023-00827-0 |
Similar Items
-
Engineered Jurkat Cells for Targeting Prostate-Specific Membrane Antigen on Prostate Cancer Cells by Nanobody-Based Chimeric Antigen Receptor
by: Mahmoud Hassani, et al.
Published: (2020-03-01) -
Engineered Jurkat Cells for Targeting Prostate-Specific Membrane Antigen on Prostate Cancer Cells by Nanobody-Based Chimeric Antigen Receptor
by: Mahmoud Hassani, et al.
Published: (2020-03-01) -
Cell-specific targeting by engineered M13 bacteriophage expressing VEGFR2 nanobody
by: Farideh Ranjibar, et al.
Published: (2018-09-01) -
VEGFA, VEGFR1, VEGFR2 serum and cerebrospinal fluid concentration in patients with acute leukemia
by: E. I. Zakharko, et al.
Published: (2024-04-01) -
An Investigation of Vascular Endothelial Growth Factor (VEGFR-1 and VEGFR-2) in Burn Wound Healing
by: L Abdulazeem, et al.
Published: (2022-04-01)